Literature DB >> 18378164

Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model.

Yinlan Bai1, Ying Xue, Hui Gao, Limei Wang, Tianbing Ding, Wentao Bai, Ailin Fan, Jianfang Zhang, Qunxing An, Zhikai Xu.   

Abstract

The completion of Mycobacterium tuberculosis genome sequence has opened a new way for the identification and characterization of bacterial antigens, such as ESAT-6, CFP10, MPT64, and Ag85 complex, which are helpful for tuberculosis control. In this work, genes of ESAT-6 and MPT64 were fused and expressed in Escherichia coli in form of inclusion bodies with a histidine tag. The expressed fusion protein was purified by nitrilotriacetic acid (Ni-NTA) affinity chromatography under denaturing conditions, and the yield was 18mg/L of culture. In mice, the purified ESAT-6-MPT64 fusion protein elicited stronger humoral response, greater splenic lymphocyte stimulated index, and higher levels of IFN-gamma and IL-12 production than that of the single MPT64 inoculation group, and rendered modest protection on the experimental tuberculosis mouse models. In short, the ESAT-6-MPT64 fusion protein might be a potential candidate vaccine for tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18378164     DOI: 10.1016/j.pep.2007.11.016

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial.

Authors:  Feng Li; Miao Xu; Lijun Zhou; Yanqing Xiong; Lu Xia; Xiaoyong Fan; Jun Gu; Jiang Pu; Shuihua Lu; Guozhi Wang
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

2.  Click DNA cycling in combination with gold nanoparticles loaded with quadruplex DNA motifs enable sensitive electrochemical quantitation of the tuberculosis-associated biomarker CFP-10 in sputum.

Authors:  Jinlong Li; Kai Hu; Zhaoli Zhang; Xiaoyan Teng; Xia Zhang
Journal:  Mikrochim Acta       Date:  2019-08-31       Impact factor: 5.833

3.  Expression and Purification of Recombinant Mycobacterium Tuberculosis (TB) Antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and Their Diagnosis Potential for Detection of TB Patients.

Authors:  M Hemmati; A Seghatoleslam; M Rasti; S Ebadat; N Mosavari; M Habibagahi; M Taheri; A R Sardarian; Z Mostafavi-Pour
Journal:  Iran Red Crescent Med J       Date:  2011-08-01       Impact factor: 0.611

Review 4.  Tuberculosis vaccine research in China.

Authors:  Douglas B Lowrie
Journal:  Emerg Microbes Infect       Date:  2012-07-25       Impact factor: 7.163

Review 5.  In silico analysis and experimental validation of Mycobacterium tuberculosis -specific proteins and peptides of Mycobacterium tuberculosis for immunological diagnosis and vaccine development.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2013-08-31       Impact factor: 1.927

6.  Potential of High-Affinity, Slow Off-Rate Modified Aptamer Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications.

Authors:  Theresa M Russell; Louis S Green; Taylor Rice; Nicole A Kruh-Garcia; Karen Dobos; Mary A De Groote; Thomas Hraha; David G Sterling; Nebojsa Janjic; Urs A Ochsner
Journal:  J Clin Microbiol       Date:  2017-08-09       Impact factor: 5.948

7.  Designing and Construction of a Cloning Vector Containing mpt64 Gene of Mycobacterium tuberculosis.

Authors:  Hosna Zare; Ehsan Aryan; Shadi Alami; Atieh Yaghoubi; Roghayeh Teimourpour; Zahra Meshkat
Journal:  Tanaffos       Date:  2018-03

8.  Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and "Non-BCG" Antigens to Induce Long-Term Immune Memory.

Authors:  Wei Lv; Pu He; Yanlin Ma; Daquan Tan; Fei Li; Tao Xie; Jiangyuan Han; Juan Wang; Youjun Mi; Hongxia Niu; Bingdong Zhu
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.